Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$205,557
-$146,787 QoQ
Shares Held
410
-52.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,276
of 2,606 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $2,686,479 across 7 Diagnostics & Research names. TMO ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
5,013 | $665,876 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,074 | $565,396 | |
| 3 | DHR |
Danaher Corp /De/
|
2,351 | $447,818 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,610 | $311,084 | |
| 5 | NTRA |
Natera, Inc.
|
1,054 | $286,108 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
This page
|
410 | $205,557 | |
| 7 | GH |
Guardant Health, Inc.
|
1,364 | $204,640 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,557 | 410 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $352,344 | 869 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $548,355 | 1,102 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $341,201 | 617 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $266,987 | 503 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||